PTPase INHIBITORS AND METHODS OF USING THE SAME

Details for Australian Patent Application No. 2003210741 (hide)

Owner THE CLEVELAND CLINIC FOUNDATION

Inventors YI, Taolin

Pub. Number AU-A-2003210741

PCT Number PCT/US03/02770

PCT Pub. Number WO2003/063788

Priority 60/353,019 30.01.02 US; 10/238,007 09.09.02 US

Filing date 30 January 2003

Wipo publication date 2 September 2003

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/353,019 30.01.02 US; 10/238,007 09.09.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003210741

14 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210742-SIGNAL ENDED LOPP LOSS MEASUREMENT BY FREQUENCY DOMAIN REFLECTOMETRY-BASED SIGNAL PROCESSING

2003210740-LIGHTWEIGHT NONWOVEN FABRIC HAVING IMPROVED PERFORMANCE